These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[X]
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
|
|
[ ]
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
(State
or other jurisdiction of
incorporation
or organization)
|
57-0426694
(IRS
Employer
Identification
Number)
|
|
|
2155
West Croft Circle
Spartanburg,
South Carolina
(Address
of principal executive offices)
|
29302
(Zip
code)
|
|
(864)
585-3605
|
|
(Registrant's
telephone number, including area
code)
|
|
Larger
accelerated filer ( )
|
Accelerated
filer ( )
|
|
Non-accelerated
filer ( )
(Do
not check if a smaller reporting company)
|
Smaller
reporting company (X)
|
|
Item
1.
|
Financial
Statements (unaudited)
|
|
Condensed
consolidated balance sheets - July 3, 2010 and January 2,
2010
|
|
|
Condensed
consolidated statements of operations - Three and six months ended July 3,
2010 and
July
4, 2009
|
|
|
Condensed
consolidated statements of cash flows - Six months ended July 3, 2010
and
July
4, 2009
|
|
|
Notes
to condensed consolidated financial statements - July 3,
2010
|
|
|
Item
2.
|
Management's
Discussion and Analysis of Financial Condition and Results of
Operations
|
|
Item
3.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
|
Item
4.
|
Controls
and Procedures
|
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
|
Item
6.
|
Exhibits
|
|
Signatures
and Certifications
|
|
|
||||||||
|
|
||||||||
|
Synalloy
Corporation
|
||||||||
|
Condensed
Consolidated Balance Sheets
|
Jul
3, 2010
|
Jan
2, 2010
|
||||||
|
(Unaudited)
|
(Note)
|
|||||||
|
Assets
|
||||||||
|
Current
assets
|
||||||||
|
Cash
and cash equivalents
|
$ | 98,955 | $ | 14,096,557 | ||||
|
Accounts
receivable, less allowance
|
||||||||
|
for
doubtful accounts
|
19,891,679 | 14,041,130 | ||||||
|
Inventories
|
||||||||
|
Raw
materials
|
13,739,782 | 8,639,078 | ||||||
|
Work-in-process
|
12,616,009 | 8,418,840 | ||||||
|
Finished
goods
|
9,334,183 | 8,446,406 | ||||||
|
Total
inventories
|
35,689,974 | 25,504,324 | ||||||
|
Income
taxes receivable
|
623,128 | 919,743 | ||||||
|
Deferred
income taxes
|
1,832,545 | 1,702,000 | ||||||
|
Prepaid
expenses and other current assets
|
268,251 | 636,680 | ||||||
|
Total
current assets
|
58,404,532 | 56,900,434 | ||||||
|
Cash
value of life insurance
|
3,011,800 | 2,959,637 | ||||||
|
Property,
plant & equipment, net of accumulated
|
||||||||
|
depreciation
of $37,386,897 and $36,732,950
|
18,342,406 | 15,796,882 | ||||||
|
Goodwill
|
2,354,730 | 2,354,730 | ||||||
|
Deferred
charges, net
|
244,272 | 240,000 | ||||||
|
Total
assets
|
$ | 82,357,740 | $ | 78,251,683 | ||||
|
Liabilities
and Shareholders' Equity
|
||||||||
|
Current
liabilities
|
||||||||
|
Accounts
payable
|
$ | 10,517,668 | $ | 6,581,631 | ||||
|
Accrued
expenses
|
4,123,907 | 5,820,748 | ||||||
|
Current
portion of environmental reserves
|
237,185 | 375,000 | ||||||
|
Total
current liabilities
|
14,878,760 | 12,777,379 | ||||||
|
Long-term
debt
|
2,312,810 | - | ||||||
|
Environmental
reserves
|
750,000 | 750,000 | ||||||
|
Deferred
compensation
|
312,076 | 380,562 | ||||||
|
Deferred
income taxes
|
1,623,000 | 1,623,000 | ||||||
|
Shareholders'
equity
|
||||||||
|
Common
stock, par value $1 per share - authorized
|
||||||||
|
12,000,000
shares; issued 8,000,000 shares
|
8,000,000 | 8,000,000 | ||||||
|
Capital
in excess of par value
|
872,906 | 856,021 | ||||||
|
Retained
earnings
|
68,692,687 | 69,113,403 | ||||||
|
Less
cost of Common Stock in treasury:
|
||||||||
|
1,714,626
and 1,733,424 shares
|
(15,084,499 | ) | (15,248,682 | ) | ||||
|
Total
shareholders' equity
|
62,481,094 | 62,720,742 | ||||||
|
Total
liabilities and shareholders' equity
|
$ | 82,357,740 | $ | 78,251,683 | ||||
|
Note:
The balance sheet at January 2, 2010 has been derived from the audited
consolidated financial statements at that date.
|
||||||||
|
See
accompanying notes to condensed consolidated financial
statements.
|
||||||||
|
Synalloy
Corporation
|
|||||||||
|
Condensed
Consolidated Statements of Operations
|
|||||||||
|
(Unaudited)
|
|||||||||
|
Three
Months Ended
|
Six
Months Ended
|
||||||||
|
Jul
3, 2010
|
Jul
4, 2009
|
Jul
3, 2010
|
Jul
4, 2009
|
||||||
|
Net
sales
|
$ 36,348,685
|
$21,691,595
|
$71,549,289
|
$52,084,899
|
|||||
|
Cost
of goods sold
|
32,138,412
|
19,707,367
|
64,589,355
|
47,184,542
|
|||||
|
Gross
profit
|
4,210,273
|
1,984,228
|
6,959,934
|
4,900,357
|
|||||
|
Selling,
general and administrative expense
|
2,502,910
|
2,317,277
|
5,130,629
|
4,662,012
|
|||||
|
Operating
income (loss)
|
1,707,363
|
(333,049)
|
1,829,305
|
238,345
|
|||||
|
Other
(income) and expense
|
|||||||||
|
Interest
expense
|
12,740
|
89,437
|
14,247
|
194,472
|
|||||
|
Change
in fair value of interest rate swap
|
-
|
(28,000)
|
-
|
(77,000)
|
|||||
|
Other,
net
|
(1,298)
|
(1,816)
|
(10,310)
|
(1,882)
|
|||||
|
Income
(loss) from continuing operations
|
|||||||||
| before income tax |
1,695,921
|
(392,670)
|
1,825,368
|
122,755
|
|||||
|
Provision
for (benefit from) income taxes
|
618,000
|
(134,000)
|
665,000
|
42,000
|
|||||
|
Net
income (loss) from continuing operations
|
1,077,921
|
(258,670)
|
1,160,368
|
80,755
|
|||||
|
Income
(loss) from discontinued
|
|||||||||
| operations before income taxes |
-
|
152,076
|
-
|
(69,604)
|
|||||
|
Tax
provision (benefit)
|
-
|
52,000
|
-
|
(24,000)
|
|||||
|
Net
income (loss) from discontinued operations
|
-
|
100,076
|
-
|
(45,604)
|
|||||
|
Net
income (loss)
|
$ 1,077,921
|
$ (158,594)
|
$ 1,160,368
|
$ 35,151
|
|||||
|
Net
income (loss) per basic common share:
|
|||||||||
|
Continuing
operations
|
$ 0.17
|
$ (0.04)
|
$ 0.18
|
$ 0.01
|
|||||
|
Discontinued
operations
|
0.00
|
0
.02
|
0.00
|
0.00
|
|||||
|
Net
income (loss)
|
$ 0.17
|
$ (0.02)
|
$ 0.18
|
$ 0.01
|
|||||
|
Net
income (loss) per diluted common share:
|
|||||||||
|
Continuing
operations
|
$ 0.17
|
$ (0.04)
|
$ 0.18
|
$ 0.01
|
|||||
|
Discontinued
operations
|
0.00
|
0.02
|
0.00
|
0.00
|
|||||
|
Net
income (loss)
|
$ 0.17
|
$ (0.02)
|
$ 0.18
|
$ 0.01
|
|||||
|
Weighted
average shares outstanding:
|
|||||||||
|
Basic
|
6,283,011
|
6,262,959
|
6,277,399
|
6,257,035
|
|||||
|
Dilutive
effect from stock
|
|||||||||
|
options
and grants
|
30,124
|
-
|
22,859
|
4,366
|
|||||
|
Diluted
|
6,313,135
|
6,262,959
|
6,300,258
|
6,261,401
|
|||||
|
See
accompanying notes to condensed consolidated financial
statements.
|
|||||||||
|
Synalloy
Corporation
|
||||||||
|
Condensed
Consolidated Statements of Cash Flows
|
||||||||
|
(Unaudited)
|
Six Months Ended
|
|||||||
|
Jul
3, 2010
|
Jul
4, 2009
|
|||||||
|
Operating
activities
|
||||||||
|
Net
income from continuing operations
|
$ | 1,160,368 | $ | 80,755 | ||||
|
Adjustments
to reconcile net income to net cash
|
||||||||
|
(used
in) provided by continuing operating activities:
|
||||||||
|
Depreciation
expense
|
1,316,675 | 1,294,624 | ||||||
|
Amortization
of deferred charges
|
- | 23,628 | ||||||
|
Deferred
income taxes
|
(130,545 | ) | (89,821 | |||||
|
Provision
for losses on accounts receivable
|
149,519 | 221,933 | ||||||
|
Provision
for losses on inventory
|
7,375 | (1,203,000 | ) | |||||
|
Gain
on sale of property, plant and equipment
|
(19,991 | ) | (18,920 | ) | ||||
|
Cash
value of life insurance
|
(52,163 | ) | (31,249 | ) | ||||
|
Environmental
reserves
|
(137,815 | ) | 54,062 | |||||
|
Issuance
of treasury stock for director fees
|
74,981 | 75,010 | ||||||
|
Employee
stock option and stock grant compensation
|
89,341 | 106,918 | ||||||
|
Change
in fair value of interest rate swap
|
- | (77,000 | ) | |||||
|
Changes
in operating assets and liabilities:
|
||||||||
|
Accounts
receivable
|
(6,000,068 | ) | 6,015,837 | |||||
|
Inventories
|
(10,193,025 | ) | 14,992,260 | |||||
|
Other
assets and liabilities
|
295,671 | (222,317 | ) | |||||
|
Income
taxes receivable
|
296,615 | 842,981 | ||||||
|
Accounts
payable
|
3,936,037 | (4,783,559 | ) | |||||
|
Accrued
expenses
|
(1,696,841 | ) | (4,138,491 | ) | ||||
|
Net
cash (used in) provided by continuing operating activities
|
(10,903,866 | ) | 13,143,651 | |||||
|
Net
cash provided by discontinued operating activities
|
- | 1,497,720 | ||||||
|
Net
cash (used in) provided by operating activities
|
(10,903,866 | ) | 14,641,371 | |||||
|
Investing
activities
|
||||||||
|
Purchases
of property, plant and equipment
|
(3,872,808 | ) | (1,026,137 | ) | ||||
|
Proceeds
from sale of property, plant and equipment
|
30,600 | 18,920 | ||||||
|
Net
cash used in continuing investing activities
|
(3,842,208 | ) | (1,007,217 | ) | ||||
|
Sale
of Organic Pigments, LLC assets, net
|
- | 1,441,006 | ||||||
|
Other
|
- | (213,796 | ) | |||||
|
Net
cash provided by discontinued operating investing
activities
|
- | 1,227,210 | ||||||
|
Net
cash (used in) provided by investing activities
|
(3,842,208 | ) | 219,993 | |||||
|
Financing
activities
|
||||||||
|
Borrowings
from (payments on) long-term debt, net
|
2,312,810 | (10,425,648 | ) | |||||
|
Dividends
paid
|
(1,581,084 | ) | (631,817 | ) | ||||
|
Proceeds
from exercised stock options
|
16,746 | - | ||||||
|
Excess
tax benefits from Stock Grant Plan
|
- | 1,914 | ||||||
|
Net
cash provided by (used in) financing activities
|
748,472 | (11,055,551 | ) | |||||
|
(Decrease)
increase in cash and cash equivalents
|
(13,997,602 | ) | 3,805,813 | |||||
|
Cash
and cash equivalents at beginning of period
|
14,096,557 | 97,215 | ||||||
|
Cash
and cash equivalents at end of period
|
$ | 98,955 | $ | 3,903,028 | ||||
|
See
accompanying notes to condensed consolidated financial
statements.
|
||||||||
|
Weighted
|
||||||||
|
Average
|
||||||||
|
Grant
Date
|
||||||||
|
Shares
|
Fair
Value
|
|||||||
|
Outstanding
at January 2, 2010
|
23,134 | $ | 17.62 | |||||
|
Granted
|
51,500 | $ | 7.88 | |||||
|
Vested
|
(7,059 | ) | $ | 19.30 | ||||
|
Forfeited
or expired
|
(19,235 | ) | $ | 8.89 | ||||
|
Outstanding
at July 3, 2010
|
48,340 | $ | 10.47 | |||||
|
THREE
MONTHS ENDED
|
SIX
MONTHS ENDED
|
|||||||||||||||
|
Jul
3, 2010
|
Jul
4, 2009
|
Jul
3, 2010
|
Jul
4, 2009
|
|||||||||||||
|
Net
sales
|
||||||||||||||||
|
Metals
Segment
|
$ | 25,137,000 | $ | 14,135,000 | $ | 50,099,000 | $ | 36,762,000 | ||||||||
|
Specialty
Chemicals Segment
|
11,212,000 | 7,557,000 | 21,450,000 | 15,323,000 | ||||||||||||
| $ | 36,349,000 | $ | 21,692,000 | $ | 71,549,000 | $ | 52,085,000 | |||||||||
|
Operating
income (loss)
|
||||||||||||||||
|
Metals
Segment
|
$ | 963,000 | $ | (108,000 | ) | $ | 561,000 | $ | 666,000 | |||||||
|
Specialty
Chemicals Segment
|
1,241,000 | 445,000 | 2,327,000 | 935,000 | ||||||||||||
| 2,204,000 | 337,000 | 2,888,000 | 1,601,000 | |||||||||||||
|
Unallocated
expenses (income)
|
||||||||||||||||
|
Corporate
|
496,000 | 671,000 | 1,059,000 | 1,364,000 | ||||||||||||
|
Interest
expense
|
13,000 | 89,000 | 14,000 | 194,000 | ||||||||||||
|
Change
in fair value of interest
|
||||||||||||||||
|
rate
swap
|
- | (28,000 | ) | - | (77,000 | ) | ||||||||||
|
Other
income
|
(1,000 | ) | (2,000 | ) | (10,000 | ) | (3,000 | ) | ||||||||
|
Income
(loss) from continuing
|
||||||||||||||||
| operations before income taxes | $ | 1,696,000 | $ | (393,000 | ) | $ | 1,825,000 | $ | 123,000 | |||||||
|
Number
of Shares
|
||||||
|
Date
Issued
|
Class
of Purchasers
|
Issued
|
Consideration
|
|||
|
4/29/2010
|
Non-Employee
Directors
(1)
|
7,655
|
Director
Services
|
|
(1)
|
Each
non-employee director was given the opportunity and has elected to receive
$15,000 of the retainer in restricted stock for 2010-11 year which equals
1,531 shares per director for a total of 7,655 shares. The number of
restricted shares issued is determined by the average of the high and low
stock priced on the day prior to the Annual Meeting of Shareholders. The
shares granted to the non-employee directors are not registered under the
Securities Act of 1933 and are subject to forfeiture in whole or in part
upon the occurrence of certain events. The number of shares in the above
chart represents the aggregate number of shares directors are entitled to
receive at the end of the Company’s second quarter and is prorated based
on the number of regular quarterly board meetings attended during each
director’s elected term.
|
|
Date
Issued
|
Class
of Purchasers
|
Number
of Shares Issued
|
Aggregate
Exercise Price
|
|||
|
5/6/2010
|
Non-Employee
Directors
|
1,500
|
$10,125
|
|
Issuer
Purchases of Equity Securities
|
||||||||||||||||
|
Quarter
Ended July 3, 2010 for the Period
|
Total
Number of Shares (1)
|
Average
Price Paid per Share (1)
|
Total
Number of Shares Purchased as Part of Publicly Announced Plans or
Programs
|
Maximum
Number of Shares that may yet be Purchased Under the Plans or
Programs
|
||||||||||||
|
04-04
to 05-01
|
- | - | - | - | ||||||||||||
|
05-02
to 05-29
|
1,016 | $ | 9.96 | - | - | |||||||||||
|
05-30
to 07-03
|
- | - | - | - | ||||||||||||
|
Total
|
1,016 | $ | 9.96 | - | - | |||||||||||
|
|
||
|
The
following exhibits are included herein:
|
||
|
31.1
|
Rule
13a-14(a)/15d-14(a) Certifications of Chief Executive Officer
|
|
|
31.2
|
Rule
13a-14(a)/15d-14(a) Certifications of Chief Financial Officer and
Principal Accounting Officer
|
|
|
32
|
Certifications
Pursuant to 18 U.S.C. Section 1350
|
|
|
SYNALLOY
CORPORATION
|
||
|
(Registrant)
|
||
|
Date:
August 12,
2010
|
By:
|
/s/ Ronald H.
Braam
|
|
Ronald
H. Braam
|
||
|
President
and Chief Executive Officer
|
||
|
Date:
August 12,
2010
|
By:
|
/s/ Richard D.
Sieradzki
|
|
Richard
D. Sieradzki
|
||
|
Chief
Financial Officer and Principal Accounting Officer
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|